List of Tables
Table 1. Global Hypoactive Sexual Desire Disorder Medication Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hypoactive Sexual Desire Disorder Medication Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hypoactive Sexual Desire Disorder Medication Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hypoactive Sexual Desire Disorder Medication Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Hypoactive Sexual Desire Disorder Medication Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hypoactive Sexual Desire Disorder Medication Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hypoactive Sexual Desire Disorder Medication Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hypoactive Sexual Desire Disorder Medication Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hypoactive Sexual Desire Disorder Medication, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hypoactive Sexual Desire Disorder Medication, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hypoactive Sexual Desire Disorder Medication, Product Type & Application
Table 12. Global Key Manufacturers of Hypoactive Sexual Desire Disorder Medication, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hypoactive Sexual Desire Disorder Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypoactive Sexual Desire Disorder Medication as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hypoactive Sexual Desire Disorder Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hypoactive Sexual Desire Disorder Medication Sales by Region (2020-2025) & (K Units)
Table 18. Global Hypoactive Sexual Desire Disorder Medication Sales Market Share by Region (2020-2025)
Table 19. Global Hypoactive Sexual Desire Disorder Medication Sales by Region (2026-2031) & (K Units)
Table 20. Global Hypoactive Sexual Desire Disorder Medication Sales Market Share by Region (2026-2031)
Table 21. Global Hypoactive Sexual Desire Disorder Medication Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Region (2020-2025)
Table 23. Global Hypoactive Sexual Desire Disorder Medication Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Region (2026-2031)
Table 25. North America Hypoactive Sexual Desire Disorder Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hypoactive Sexual Desire Disorder Medication Sales by Country (2020-2025) & (K Units)
Table 27. North America Hypoactive Sexual Desire Disorder Medication Sales by Country (2026-2031) & (K Units)
Table 28. North America Hypoactive Sexual Desire Disorder Medication Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hypoactive Sexual Desire Disorder Medication Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hypoactive Sexual Desire Disorder Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hypoactive Sexual Desire Disorder Medication Sales by Country (2020-2025) & (K Units)
Table 32. Europe Hypoactive Sexual Desire Disorder Medication Sales by Country (2026-2031) & (K Units)
Table 33. Europe Hypoactive Sexual Desire Disorder Medication Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hypoactive Sexual Desire Disorder Medication Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hypoactive Sexual Desire Disorder Medication Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hypoactive Sexual Desire Disorder Medication Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Hypoactive Sexual Desire Disorder Medication Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Hypoactive Sexual Desire Disorder Medication Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hypoactive Sexual Desire Disorder Medication Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hypoactive Sexual Desire Disorder Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hypoactive Sexual Desire Disorder Medication Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Hypoactive Sexual Desire Disorder Medication Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Hypoactive Sexual Desire Disorder Medication Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hypoactive Sexual Desire Disorder Medication Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hypoactive Sexual Desire Disorder Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hypoactive Sexual Desire Disorder Medication Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Hypoactive Sexual Desire Disorder Medication Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Hypoactive Sexual Desire Disorder Medication Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hypoactive Sexual Desire Disorder Medication Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hypoactive Sexual Desire Disorder Medication Sales (K Units) by Type (2020-2025)
Table 51. Global Hypoactive Sexual Desire Disorder Medication Sales (K Units) by Type (2026-2031)
Table 52. Global Hypoactive Sexual Desire Disorder Medication Sales Market Share by Type (2020-2025)
Table 53. Global Hypoactive Sexual Desire Disorder Medication Sales Market Share by Type (2026-2031)
Table 54. Global Hypoactive Sexual Desire Disorder Medication Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hypoactive Sexual Desire Disorder Medication Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Type (2020-2025)
Table 57. Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Type (2026-2031)
Table 58. Global Hypoactive Sexual Desire Disorder Medication Price (US$/Unit) by Type (2020-2025)
Table 59. Global Hypoactive Sexual Desire Disorder Medication Price (US$/Unit) by Type (2026-2031)
Table 60. Global Hypoactive Sexual Desire Disorder Medication Sales (K Units) by Application (2020-2025)
Table 61. Global Hypoactive Sexual Desire Disorder Medication Sales (K Units) by Application (2026-2031)
Table 62. Global Hypoactive Sexual Desire Disorder Medication Sales Market Share by Application (2020-2025)
Table 63. Global Hypoactive Sexual Desire Disorder Medication Sales Market Share by Application (2026-2031)
Table 64. Global Hypoactive Sexual Desire Disorder Medication Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hypoactive Sexual Desire Disorder Medication Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Application (2020-2025)
Table 67. Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Application (2026-2031)
Table 68. Global Hypoactive Sexual Desire Disorder Medication Price (US$/Unit) by Application (2020-2025)
Table 69. Global Hypoactive Sexual Desire Disorder Medication Price (US$/Unit) by Application (2026-2031)
Table 70. Sprout Pharmaceuticals, Inc. Company Information
Table 71. Sprout Pharmaceuticals, Inc. Description and Business Overview
Table 72. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Product
Table 74. Sprout Pharmaceuticals, Inc. Recent Developments/Updates
Table 75. Covis Pharma GmbH Company Information
Table 76. Covis Pharma GmbH Description and Business Overview
Table 77. Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Product
Table 79. Covis Pharma GmbH Recent Developments/Updates
Table 80. Mylan N.V. Company Information
Table 81. Mylan N.V. Description and Business Overview
Table 82. Mylan N.V. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Mylan N.V. Hypoactive Sexual Desire Disorder Medication Product
Table 84. Mylan N.V. Recent Developments/Updates
Table 85. Teva Pharmaceutical Industries Ltd. Company Information
Table 86. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 87. Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Product
Table 89. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 90. Amneal Pharmaceuticals LLC. Company Information
Table 91. Amneal Pharmaceuticals LLC. Description and Business Overview
Table 92. Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Product
Table 94. Amneal Pharmaceuticals LLC. Recent Developments/Updates
Table 95. Zydus Group Company Information
Table 96. Zydus Group Description and Business Overview
Table 97. Zydus Group Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Zydus Group Hypoactive Sexual Desire Disorder Medication Product
Table 99. Zydus Group Recent Developments/Updates
Table 100. Sun Pharmaceutical Industries Ltd Company Information
Table 101. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 102. Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Product
Table 104. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 105. Abbvie,Inc Company Information
Table 106. Abbvie,Inc Description and Business Overview
Table 107. Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Product
Table 109. Abbvie,Inc Recent Developments/Updates
Table 110. EndoCeutics, Inc. Company Information
Table 111. EndoCeutics, Inc. Description and Business Overview
Table 112. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Product
Table 114. EndoCeutics, Inc. Recent Developments/Updates
Table 115. S1 BIOPHARMA INC. Company Information
Table 116. S1 BIOPHARMA INC. Description and Business Overview
Table 117. S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Product
Table 119. S1 BIOPHARMA INC. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Hypoactive Sexual Desire Disorder Medication Distributors List
Table 123. Hypoactive Sexual Desire Disorder Medication Customers List
Table 124. Hypoactive Sexual Desire Disorder Medication Market Trends
Table 125. Hypoactive Sexual Desire Disorder Medication Market Drivers
Table 126. Hypoactive Sexual Desire Disorder Medication Market Challenges
Table 127. Hypoactive Sexual Desire Disorder Medication Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hypoactive Sexual Desire Disorder Medication
Figure 2. Global Hypoactive Sexual Desire Disorder Medication Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hypoactive Sexual Desire Disorder Medication Market Share by Type: 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. Parenteral Product Picture
Figure 6. Others Product Picture
Figure 7. Global Hypoactive Sexual Desire Disorder Medication Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Hypoactive Sexual Desire Disorder Medication Market Share by Application: 2024 & 2031
Figure 9. Hospital Pharmacy
Figure 10. Online Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Global Hypoactive Sexual Desire Disorder Medication Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Hypoactive Sexual Desire Disorder Medication Market Size (2020-2031) & (US$ Million)
Figure 14. Global Hypoactive Sexual Desire Disorder Medication Sales (2020-2031) & (K Units)
Figure 15. Global Hypoactive Sexual Desire Disorder Medication Average Price (US$/Unit) & (2020-2031)
Figure 16. Hypoactive Sexual Desire Disorder Medication Report Years Considered
Figure 17. Hypoactive Sexual Desire Disorder Medication Sales Share by Manufacturers in 2024
Figure 18. Global Hypoactive Sexual Desire Disorder Medication Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Hypoactive Sexual Desire Disorder Medication Players: Market Share by Revenue in Hypoactive Sexual Desire Disorder Medication in 2024
Figure 20. Hypoactive Sexual Desire Disorder Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Hypoactive Sexual Desire Disorder Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Hypoactive Sexual Desire Disorder Medication Sales Market Share by Country (2020-2031)
Figure 23. North America Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Country (2020-2031)
Figure 24. United States Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Hypoactive Sexual Desire Disorder Medication Sales Market Share by Country (2020-2031)
Figure 27. Europe Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Country (2020-2031)
Figure 28. Germany Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Hypoactive Sexual Desire Disorder Medication Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Region (2020-2031)
Figure 35. China Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Hypoactive Sexual Desire Disorder Medication Sales Market Share by Country (2020-2031)
Figure 43. Latin America Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Hypoactive Sexual Desire Disorder Medication Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Hypoactive Sexual Desire Disorder Medication Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Hypoactive Sexual Desire Disorder Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Hypoactive Sexual Desire Disorder Medication by Type (2020-2031)
Figure 53. Global Revenue Market Share of Hypoactive Sexual Desire Disorder Medication by Type (2020-2031)
Figure 54. Global Hypoactive Sexual Desire Disorder Medication Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Hypoactive Sexual Desire Disorder Medication by Application (2020-2031)
Figure 56. Global Revenue Market Share of Hypoactive Sexual Desire Disorder Medication by Application (2020-2031)
Figure 57. Global Hypoactive Sexual Desire Disorder Medication Price (US$/Unit) by Application (2020-2031)
Figure 58. Hypoactive Sexual Desire Disorder Medication Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
